Qube Research & Technologies LTD Mesoblast LTD Transaction History

Qube Research & Technologies LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$1.0 - $1.39 $4,048 - $5,626	-4,048 Reduced 49.18%	4,183 $4,000
Q3 2023 Nov 13, 2023	BUY	$1.22 - $4.83 $10,041 - $39,755	8,231 New	8,231 $10,000
Q1 2021 May 14, 2021	SELL	$8.26 - $11.4 $158,905 - $219,313	-19,238 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$8.21 - $18.59 $157,943 - $357,634	19,238 New	19,238 $163,000
Q3 2020 Nov 12, 2020	SELL	$11.33 - $19.81 $803,670 - $1.41 Million	-70,933 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$4.2 - $15.45 $297,918 - $1.1 Million	70,933 New	70,933 $808,000

151K

Ticker MESO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 147,316,000
Market Cap $2.51B
Description
Mesoblast Limited, a biopharmaceutical company, develops and commercializes allogeneic cellular medicines in the United States, Australia, Singapore, the United Kingdom, and Switzerland. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its ...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.